Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1621
-
1622
-
1623
-
1624
-
1625
-
1626
-
1627
-
1628
-
1629
-
1630
-
1631
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
Published 2018“…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. We aimed to investigate the safety and efficacy of AZP-531 in patients with PWS for whom no approved treatment for hyperphagia is currently available.…”
-
1632
Substrate cross-links to TatA and TatC have comparable detection limits when substrate levels are gradually decreased.
Published 2015“…<p>Detection of cross-links of RR-HiPIP with <i>p</i>Bpa at position A13 (RR-A13<i>p</i>Bpa) either to wild-type level non-recombinant TatA in the absence of TatBC (left section: <i>tatAB</i><sup>-</sup><i>C</i><sup>-</sup>, strain JBdBC) or to wild-type level non-recombinant TatBC in the absence of TatA (right section: <i>tatA</i><sup>-</sup><i>BC</i>; strain JARV16). …”
-
1633
-
1634
-
1635
-
1636
-
1637
-
1638
-
1639
-
1640